EFFECT OF COVID-19 INFECTION ON PREGNANCY-INDUCE HYPERCOAGULABILITY
ВЛИЯНИЕ ИНФЕКЦИИ COVID-19 НА ГИПЕРКОАГУЛЯЦИЮ, ВЫЗВАННУЮ БЕРЕМЕННОСТЬЮ
Abstract
COVID-19 is one of the most wide-spread pandemics in more than 100 years. At the time of writing this case report (Dec 19, 2020), there has already been a total of 75.5 million cases and 1.6 million deaths since the onset of the pandemic [3,6,7]. Although we have a good understanding of how various comorbidities affect the outcome of COVID-19 patients, we have less data about the clinical course of COVID-19 in pregnant patients [4,5]. One of the most significant aspect of pregnancy and concomitant COVID-19 is the risk of hypercoagulable complications in the patient [4,10]. Pregnant women are already at high risk of thrombotic conditions due to physiologic changes in pregnancy and COVID-19 has also been shown to exacerbate hypercoagulability [8,9]. Here we report the case series about 7 patients with significant laboratory derangement possibly indicating worsening hypercoagulability. We believe that correlation between pregnancy and COVID-19 induced hypercoagulability will give rise to many further questions and the answers from the medical society will likely prevent many cases of life-threatening thrombotic complications in pregnant women across the world.
Downloads
References
L. Ratiani, T. Didbaridze, N. Pkhaladze, et. al. Clinical, laboratory and virology data of four pregnant women with COVID-19 in Georgia: A Retrospective study. Accessed on 14rd Dec.2020
Organization. WH (2005) Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)
Center for Systems Science and Engineering, Johns Hopkins University Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering at JHU Accessed 23rd Mar 2020
H. Chen, J. Guo, C. Wang, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records, Lancet, 395 (2020), pp. 809-815
D. Di Mascio, A. Khalil, G. Saccone, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis Am J Obstet Gynecol MFM, 2 (2020), p. 100107
Gottfredsson M.The Spanish flu in Iceland 1918. Lessons in medicine and history. Laeknabladid. 2008; 94: 737-745
Jamieson D.J.Honein M.A. Rasmussen S.A. et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009; 374: 451-458
Schwartz D.A.Graham A.L. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020; 12: 194
Kwon JY, Romero R, Mor G. New insights into the relationship between viral infection and pregnancy complications. Am J Reprod Immunol. 2014;71(5):387–390. doi: 10.1111/aji.12243.
Cunningham FG. Normal reference ranges for laboratory values in pregnancy. UpToDate. https://www.uptodate.com/contents/normal-reference-ranges-for-laboratory-values-in-pregnancy?search=D-dimer+in+pregnancy. Published May 1, 2020. Accessed December 22, 2020.
